A thread on some pointers from the Annual Report of #hikal:
- entry into new markets
- strong cash flow of 180cr used towards capex+dept repayment - in animal health signed a 10-year contract with a leading MNC for development+supply of niche APIs
(1/10) 🧵
- animal health to be made major verticle. flexible manufacturing facility for same to be added at Panoli plant.
- 3.3% of annual sales in R&D
- focus on backward integration of raw materials to help reduce supplier concentration and geographical dependence